 RALEIGH, N.C., Nov. 04, 2020 GLOBE NEWSWIRE -- BioDelivery Sciences International, Inc. NASDAQ: BDSI, a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that its Board of Directors has authorized the repurchase of up to 25 million of the Companys shares of common stock. 